About Global Health Limited (Medanta)

Global Health Limited (Medanta) was founded by Dr. Naresh Trehan to build a sustainable, large-format healthcare platform delivering comprehensive, world-class care under one roof. Over 15 years, Medanta has evolved into a multi-speciality, tertiary and quaternary care provider with hospitals, clinics, labs, pharmacies, home care and digital health, anchored in a collaborative, patient-centred “Medanta Model of Care”. The company has touched the lives of over 2.5 million patients from India and abroad, and has pioneered advanced procedures including non-invasive mitral valve repair and robotic surgery. Its Gurugram hospital became the first in India to use AI-enabled Penumbra Lightning technology for treating pulmonary embolism. The year also saw an advanced NICU ambulance and child development centre launched in Lucknow, and a comprehensive cancer institute with the Varian EDGE system unveiled in Patna.

Medanta operates across key Indian cities including Gurugram, Lucknow, Patna, Indore and Ranchi, and is expanding with new facilities planned in Noida, Delhi (Pitampura and South Delhi), Mumbai (Oshiwara) and Guwahati. Its integrated network includes eight multi-speciality Medanta Clinics, a 24×7 e-ICU Command Centre, 10 laboratories with over 300 collection centres, eight retail pharmacies, and Home Care services in Gurugram, Lucknow, Patna and Indore. As on March 31, 2025, the company had four subsidiaries.

Global Health Limited Key Management

• Dr. Naresh Trehan – Chairman and Managing Director

• Mr. Pankaj Sahni – Whole-time Director & CEO

• Mr. Yogesh Gupta – CFO

• Mr. Rahul Ranjan – Company Secretary & Compliance Officer

Latest Updates on Global Health Limited (Medanta)

• Expansion pipeline: Medanta plans to add over 3,000 beds through strategically located brownfield and greenfield projects. During the year, it announced three large-format greenfield hospitals in Mumbai (Oshiwara), Pitampura (Delhi) and Guwahati, expected to collectively add around 2,000 beds over 3 to 4 years. About 1,000 additional beds are to be added across Noida, Lucknow, Patna and Ranchi, including a newly built, 110-bedded facility in Ranchi expected to operationalise in Q2 FY26. A state-of-the-art 550-bedded hospital in Noida is also targeted to operationalise in Q2 FY26.

• New facilities and integrated network: Medanta operationalised hospitals in Indore and Ranchi, and continued to scale its continuum of care with eight clinics, an e-ICU Command Centre, 10 labs with 300+ collection centres, eight pharmacies, and Home Care services in multiple cities.

• Projects in Delhi-NCR and Gurugram campus: Construction started in June 2025 on a 400-bed super speciality hospital in South Delhi; plans are also underway for a super speciality hospital in Northwest Delhi. Medanta will develop a guest house and establish a world-class Medical College in Gurugram with an investment of Rs 250 crore; regulatory processes and early-stage works are in progress.

• Corporate actions and structure: The amalgamation of Medanta Holdings Private Limited with the Company became effective via NCLT order dated February 20, 2025. The Company allotted 80,000 equity shares under ESOP 2016 on July 12, 2024 and November 14, 2024. The last tranche of Rs 100 crore Non-Convertible Debentures issued to Asian Development Bank was redeemed in May 2024.

• Recognition: Medanta was recognised by Newsweek for six consecutive years as India’s best private hospital.